Pharmaceutical companies are better positioned to understand what information physicians want—and how to generate it quickly ...
The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...
The agency’s decision to conceal drug names on inspection reports has prevented doctors, pharmacists and patients from ...
The U.S. Food and Drug Administration recalled more than 140,000 bottles of a common statin medication. Is your medication ...
In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...
The U.S. Food and Drug Administration (FDA) is warning consumers, patients and health care providers about the potential risk for serious complications from radiofrequency (RF) microneedling ...
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.
More than half a million bottles of blood pressure medication are being recalled over a cancer-causing chemical connected to ...
On September 9, 2025, President Trump issued a Presidential Memorandum directing the Secretary of Health and Human Services ...
In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive care options, covering treatments for acute myeloid leukemia (AML), ...
Health Secretary Robert F. Kennedy Jr.’s latest action takes aim at fluoride, a chemical that is a mainstay of dental care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback